[Proposals for an outline of fibrinolytic-clearing therapy in coronary diseases].
D000255:Adenosine Triphosphate / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy* / Q000517:prevention & control; D004357:Drug Synergism; D004562:Electrocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010908:Pituitary Hormones, Anterior / Q000627:therapeutic use; D008083:beta-Lipotropin / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D010908:Pituitary Hormones, Anterior; D000255:Adenosine Triphosphate; D006493:Heparin; D008083:beta-Lipotropin; D001205:Ascorbic Acid
Proposte per uno schema di terapia fibrinolitico-chiarificante della malattia coronarica.